Inventor · disambiguated record
George G. Klee
Also filed as: KLEE GEORGE · KLEE GEORGE G
8 granted patents·4 pending applications·280 citations·filing 1982–2015
89Inventor score
Top patents by PatentIndex Score
12 records- 0188US5891651AMethods of recovering colorectal epithelial cells or fragments thereof from stoolMAYO FOUNDATION·Filed 1996·Granted Apr 6, 1999·109 cites·15 claims
- 0287US8273539B2Extracellular and membrane-associated prostate cancer markersKLEE GEORGE G·Filed 2007·Granted Sep 25, 2012·14 cites·3 claims
- 0385US10407731B2Biomarker panels for predicting prostate cancer outcomesMAYO FOUND MEDICAL EDUCATION & RES·Filed 2015·Granted Sep 10, 2019·9 cites·11 claims
- 0478US6787361B1Clinical assay calibration adjustment methodMAYO FOUNDATION·Filed 2001·Granted Sep 7, 2004·22 cites·30 claims
- 0575US5516639AAntibodies specific for human prostate glandular kallkreinMAYO FOUNDATION·Filed 1993·Granted May 14, 1996·49 cites·13 claims
- 0675US4461603ADrilling fixtureCINCINNATI TOOL·Filed 1982·Granted Jul 24, 1984·44 cites·5 claims
- 0768US6235486B1Method for detection of breast cancerMAYO FOUNDATION·Filed 1998·Granted May 22, 2001·33 cites·9 claims
- 0861US2015024420A1Extracellular and membrane-associated prostate cancer markersMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 0956US8871451B2Extracellular and membrane-associated prostate cancer markersKLEE GEORGE G·Filed 2012·Granted Oct 28, 2014·0 cites·5 claims
- 1053US2009005267A1Immunoassay for cross-reacting substancesINVITROGEN CORP·Filed 2008·Application pending·0 cites
- 1150US2009298082A1Biomarker panels for predicting prostate cancer outcomesKLEE GEORGE G·Filed 2009·Application pending·0 cites
- 1248US2011136259A1Immunoassay for cross-reacting substancesLIFE TECHNOLOGIES CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George G. Klee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →